How to decide on the optimal duration of anticoagulatn therapy in carriers of the factor V Leiden mutation.
Middeldorp
S
S
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. S.Middeldorp@amc.uva.nl
Büller
H R
HR
D000925:Anticoagulants / Q000008:administration & dosage*; D003657:Decision Making; D005165:Factor V / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D009154:Mutation
D000925:Anticoagulants; C095381:factor V Leiden; D005165:Factor V